Non-GAAP Financial Measures Reconciliation
The Non-GAAP Financial Measures presented at the Sidoti & Company Fall Conference on September 28, 2017 include the following:
The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is included in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company includes in Adjusted EBITDA three categories of items: 1) Base EBITDA components, including: earnings before discontinued operations, interest (including change in fair value of interest rate swap), income taxes, depreciation and amortization, 2) Material transaction based items that have no relationship to earnings from operations of past, current or future periods, including: goodwill impairment, acquisition costs, acquisition related retention costs, shelf registration costs, earn-out adjustments, gain on excess death benefit, (gains) losses associated with Sale-leaseback, stock option/grant costs, casualty insurance gain and other adjustments (lesser value items meeting the criteria, where cumulative impact in a period is material), and 3) Inventory valuation adjustments, including: a) Inventory Pricing Change - the calculated value that profits would improve (decline) if metal and alloy pricing indices were neutral period to period, b) Inventory Cost and Aged Inventory Adjustments - value of periodic adjustment to inventory carrying value unrelated to the periodic earnings, and c) Manufacturing Variances - the calculated value to apply favorable (unfavorable) manufacturing absorption in the period actually incurred, rather than through inventory valuation amortization. This treatment shows the real operational impact on earnings of higher or lower manufacturing activity levels.
For this presentation, costs that were incurred in a specific year that pertained to prior periods were excluded from Adjusted EBITDA in order to present comparable values for ongoing operations. In the Specialty Chemicals Segment, the amount added back for accounts receivable write off represents a significant one-time, extraordinary adjustment for the account balances of four long-standing customers who experienced significant financial hardship during 2011. The Metals Segment added back costs in 2010 - 2014 associated with the discontinued operations of the two fabrication facilities, which closed in 2014, that would remain with the company (i.e., corporate allocation, labor allocation, building depreciation, etc). For this presentation, these on-going costs were absorbed at the Corporate level for Adjusted EBITDA and not reflected in the Metals Segment EBITDA for comparability.
The Company began adding back stock option / stock grant compensation costs to Adjusted EBITDA in 2015. Accordingly, all years prior to 2015 do not reflect this add back.
The disclosed Non-GAAP measures are reconciled to its comparable financial measures on a GAAP basis in the following schedule. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.
Forward-Looking Statements
This report includes and incorporates by reference "forward-looking statements" within the meaning of the federal securities laws. All statements that are not historical facts are "forward-looking statements." The words "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions identify forward-looking statements. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs; raw materials availability; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; customer delays or difficulties in the production of products; new fracking regulations; a prolonged decrease in oil and nickel prices; unforeseen delays in completing the integrations of acquisitions; risks associated with mergers, acquisitions, dispositions and other expansion activities; financial stability of our customers; environmental issues; unavailability of debt financing on acceptable terms and exposure to increased market interest rate risk; inability to comply with covenants and ratios required by our debt financing arrangements; ability to weather an economic downturn; loss of consumer or investor confidence and other risks detailed from time-to-time in the Company's Securities and Exchange Commission filings. The Company assumes no obligation to update the information included in this report.
Contact: Dennis Loughran at (804) 822-3266
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Reconciliation of Net Income (Loss) to Adjusted EBITDA |
(unaudited) | Projected | | | | | | | | | | | | | | |
Amounts shown in $ millions | 2017 | | 2016 | | 2015 | | 2014 | | 2013 | | 2012 | | 2011 | | 2010 |
Consolidated | | | | | | | | | | | | | | | |
Net income (loss) from continuing operations | $ | 4.6 |
| | $ | (7.0 | ) | | $ | (10.3 | ) | | $ | 12.6 |
| | $ | 2.9 |
| | $ | 4.0 |
| | $ | 2.5 |
| | $ | (0.6 | ) |
Adjustments: | | | | | | | | | | | | | | | |
| Interest expense | 1.2 |
| | 0.9 |
| | 1.4 |
| | 1.2 |
| | 1.4 |
| | 0.6 |
| | 0.1 |
| | 0.1 |
|
| Change in fair value of interest | | | | | | | | | | | | | | | |
| rate swap | — |
| | — |
| | — |
| | 0.4 |
| | (0.7 | ) | | 0.1 |
| | — |
| | — |
|
| Income taxes | 2.0 |
| | (2.2 | ) | | 1.8 |
| | 5.4 |
| | 1.2 |
| | 1.9 |
| | 1.2 |
| | (0.4 | ) |
| Depreciation | 5.7 |
| | 4.3 |
| | 4.3 |
| | 3.8 |
| | 2.9 |
| | 2.4 |
| | 2.2 |
| | 2.2 |
|
| Amortization | 2.4 |
| | 2.5 |
| | 2.3 |
| | 1.4 |
| | 1.6 |
| | 0.6 |
| | — |
| | — |
|
| Inventory Pricing Change | (1.1 | ) | | 5.8 |
| | 6.8 |
| | 0.1 |
| | 3.4 |
| | 4.4 |
| | 1.6 |
| | (1.0 | ) |
| Inventory Cost Adjustment | (0.3 | ) | | (1.9 | ) | | 0.8 |
| | — |
| | (0.2 | ) | | 0.2 |
| | — |
| | — |
|
| Aged Inventory Adjustment | 0.1 |
| | 0.1 |
| | (0.2 | ) | | — |
| | — |
| | 0.1 |
| | — |
| | 0.1 |
|
| Acquisition costs | 1.0 |
| | 0.1 |
| | 0.5 |
| | 0.3 |
| | 0.3 |
| | 0.9 |
| | — |
| | — |
|
| Shelf registration costs | — |
| | 0.1 |
| | 0.1 |
| | — |
| | 0.3 |
| | — |
| | — |
| | — |
|
| Earn-out adjustments | — |
| | — |
| | (4.9 | ) | | (3.5 | ) | | — |
| | — |
| | — |
| | — |
|
| Bargain purchase gain on CRI, net of tax | — |
| | — |
| | — |
| | — |
| | (1.1 | ) | | — |
| | — |
| | — |
|
| Manufacturing Variances | 0.6 |
| | (0.5 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Casualty insurance gain | — |
| | — |
| | (0.9 | ) | | — |
| | — |
| | — |
| | — |
| | — |
|
| Goodwill impairment charge | — |
| | — |
| | 17.2 |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Gain on excess death benefit | — |
| | — |
| | (0.1 | ) | | — |
| | (0.1 | ) | | 0.1 |
| | — |
| | — |
|
| Other adjustments | — |
| | 0.1 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Stock option / grant costs | 0.6 |
| | 0.5 |
| | 0.5 |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Net sale-leaseback activity | 0.1 |
| | 2.6 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Retention expense | 0.1 |
| | 0.1 |
| | 0.1 |
| | — |
| | 0.2 |
| | 0.1 |
| | — |
| | — |
|
| Accounts receivable write-off | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 1.0 |
| | — |
|
Adjusted EBITDA | $ | 17.0 |
| | $ | 5.5 |
| | $ | 19.4 |
| | $ | 21.7 |
| | $ | 12.1 |
| | $ | 15.4 |
| | $ | 8.6 |
| | $ | 0.4 |
|
| | | | | | | | | | | | | | | | |
Metals Segment | | | | | | | | | | | | | | | |
Operating income (loss) from | | | | | | | | | | | | | | | |
continuing operations | $ | 8.3 |
| | $ | (7.0 | ) | | $ | (13.1 | ) | | $ | 13.5 |
| | $ | 1.3 |
| | $ | 5.7 |
| | $ | 4.0 |
| | $ | (3.3 | ) |
Adjustments: | | | | | | | | | | | | | | | |
| Depreciation expense | 4.1 |
| | 2.7 |
| | 2.9 |
| | 2.7 |
| | 2.2 |
| | 1.8 |
| | 1.7 |
| | 1.6 |
|
| Amortization expense | 2.4 |
| | 2.4 |
| | 2.3 |
| | 1.4 |
| | 1.5 |
| | 0.5 |
| | — |
| | — |
|
| Inventory Pricing Change | (1.1 | ) | | 5.8 |
| | 6.8 |
| | 0.1 |
| | 3.4 |
| | 4.4 |
| | 1.6 |
| | (1.0 | ) |
| Inventory Cost Adjustment | (0.3 | ) | | (1.9 | ) | | 0.8 |
| | — |
| | (0.2 | ) | | 0.2 |
| | — |
| | — |
|
| Aged Inventory Adjustment | 0.1 |
| | 0.1 |
| | (0.2 | ) | | — |
| | — |
| | 0.1 |
| | — |
| | 0.1 |
|
| Acquisition costs | 0.3 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Goodwill impairment charge | — |
| | — |
| | 17.2 |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Manufacturing Variances | 0.7 |
| | (0.5 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Other adjustments | — |
| | 0.1 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Stock option / grant costs | 0.2 |
| | 0.1 |
| | 0.1 |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Net sale-leaseback activity | (0.2 | ) | | 2.2 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Retention expense | 0.1 |
| | 0.1 |
| | 0.1 |
| | — |
| | 0.2 |
| | 0.1 |
| | — |
| | — |
|
| Costs retained from discontinued operations | — |
| | — |
| | — |
| | 0.8 |
| | 0.7 |
| | 0.9 |
| | 1.0 |
| | 1.0 |
|
Metals Segment Adjusted EBITDA | $ | 14.6 |
| | $ | 4.1 |
| | $ | 16.9 |
| | $ | 18.5 |
| | $ | 9.1 |
| | $ | 13.7 |
| | $ | 8.3 |
| | $ | (1.6 | ) |
| | | | | | | | | | | | | | | | |
Specialty Chemicals Segment | | | | | | | | | | | | | | | |
Operating income | $ | 6.6 |
| | $ | 4.7 |
| | $ | 5.7 |
| | $ | 6.1 |
| | $ | 5.7 |
| | $ | 4.8 |
| | $ | 2.2 |
| | $ | 4.0 |
|
Adjustments: | | | | | | | | | | | | | | | |
| Depreciation expense | 1.3 |
| | 1.5 |
| | 1.4 |
| | 1.0 |
| | 0.7 |
| | 0.5 |
| | 0.4 |
| | 0.4 |
|
| Manufacturing Variances | (0.2 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Other adjustments | — |
| | 0.1 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Stock option / grant costs | 0.1 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Net sale-leaseback activity | (0.1 | ) | | 0.2 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
| Accounts receivable write-off | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 1.0 |
| | — |
|
Adjusted EBITDA | $ | 7.7 |
| | $ | 6.5 |
| | $ | 7.1 |
| | $ | 7.1 |
| | $ | 6.4 |
| | $ | 5.3 |
| | $ | 3.6 |
| | $ | 4.4 |
|